MQX‐503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: A randomized, controlled trial

Naomi Rothfield, Lee Shapiro, David Fiorentino, Lorinda Chung, Christopher Denton, Ariane Herrick, Murray Baron, Joseph Shanahan, Vivien Hsu, Jill Belch, Virginia Steen, Agneta Scheja, Richard Martin, Edwin Smith, Maureen Mayes, Robert Simms, Janet Pope, Bashar Kahaleh, Mary Ellen Csuka, Barry GruberDavid Collier, Nadera Sweiss, Sangeeta Sule, Paul Emery, Fredrick M. Wigey

    Research output: Contribution to journal › Book/Film/Article review › peer-review

    Fingerprint

    Dive into the research topics of 'MQX‐503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: A randomized, controlled trial'. Together they form a unique fingerprint.

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science